Reed Sets Out Priorities For US Biosimilars Forum

New Executive Director Julie Reed Also Highlights Benefits Of Diverse Membership

In an exclusive interview with Generics Bulletin, the Biosimilars Forum’s executive director Julie Reed sets out the group’s priorities and explains how its diverse membership is helping to position it as a leading voice for the US biosimilars industry.

Speech Balloons Diverse Voices
The Biosimilars Forum represents a range of industry voices • Source: Kristaps Eberlins / Alamy Stock Vector

More from Leadership

More from Generics Bulletin